Open Medicine
(Apr 2021)
A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
Chen Qiang,
Hu Zunqi,
Zhang Xin,
Wei Ziran,
Fu Hongbing,
Yang DeJun,
Cai Qingping
Affiliations
Chen Qiang
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Hu Zunqi
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Zhang Xin
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Wei Ziran
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Fu Hongbing
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Yang DeJun
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Cai Qingping
Department of Gastrointestinal Surgery, Changzheng Hospital, Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
DOI
https://doi.org/10.1515/med-2021-0241
Journal volume & issue
Vol. 16,
no. 1
Abstract
Read online
This study aimed to develop a multi-long noncoding RNA (lncRNA) signature for the prediction of gastric cancer (GC) based on differential gene expression between recurrence and nonrecurrence patients.
Keywords
WeChat QR code
Close
